The novel treatment of the medication represents a major advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide573977.blogminds.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-38892084